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Abstract
As the incidence of non-melanoma skin cancer (NMSC) is increasing, there is a growing need to 
identify effective preventive strategies. A recently proposed hypothesis states that NMSC 
photocarcinogenesis is tightly linked to insufficient insulin growth factor-1 expression by 
agglomerated senescent fibroblasts in geriatric dermis. This paucity of IGF-1 expression in senile 
skin allows basal keratinocytes to mitotically propagate their UVB-altered genome and potentially 
initiate an actinic neoplasm. Here we review the role of the dermal microenvironment in NMSC 
pathogenesis, describe the impact of fibroblast senescence on this process and discuss how laser-
induced dermal wounding can be effectively used to prevent NMSC development in geriatric 
patients.
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INTRODUCTION
Cancers of the skin are the most common of all types of cancers according to the American 
Cancer Society (1), existing predominantly as basal cell carcinoma, squamous cell cancer 
(SCC) and melanoma. The first two which can be grouped as non-melanoma skin cancers 
(NMSC), occur in more than 2.2 million patients in the United States each year (1,2). The 
enormity of NMSC incidence necessitates more intensive translational cutaneous research 
that will develop preventive as well as therapeutic strategies in dermato-oncology. In this 
review, we will illustrate how results of a “bench-to-bedside” strategy in modern medicine 
can propose an expansion of common uses of therapeutic lasers in preventive dermatology. 
We are thus hoping to offer a basic science justification why an ounce of potential 
prophylactic treatment for SCC is worth a pound of its cure (3).
Notably, many signaling pathways have been investigated thus far in the context of how 
epidermal keratinocytes upon life-time exposure to UVB, eventually accumulate radiation-
induced DNA damage (4,5). Nevertheless, none of these pathways was able to offer a good 
justification of evident epidemiological data - why NMSC primarily occurs in the elderly. It 
is logical to target basic science efforts to examine signaling pathways frequently disturbed 
in geriatric skin following UVB irradiation. The insulin-like growth factor-1/insulin-like 
growth factor-1 receptor (IGF-1/IGF-1R) pathway (6–8) is one such pathway. Recent 
published reports have shown that the severity of DNA damage in keratinocytes directly 
correlates to the intensity of UVB exposure and that the state of activation of the IGF-1/
IGF-1R pathway is critical to propensity of one to develop the NMSC. Furthermore, this 
activation is directly linked to the cellular senescence profile of dermal fibroblasts in the 
dermal-epidermal niche in aged skin. More precisely, the production of IGF-1 found in 
dermal fibroblasts of young skin is suppressed in older, geriatric skin. This loss of IGF-1 
expression in geriatric skin has severe consequences on how geriatric keratinocytes react to 
UVB exposure. Keratinocytes could have several destinies depending on the dose of UVB 
light and the pre-existing activity of IGF-1/IGF-1R pathway. This behavior is mostly 
observed in response to intermediate doses of UVB: (a) if the IGF-1R is active, 
keratinocytes partially repair their DNA and favorably undergo stress-induced senescence, 
but (b) if the IGF-1R is inactive, keratinocytes cannot repair DNA damage and either 
continue to proliferate carrying malignancy prone DNA damage or under rare occasions are 
predetermined toward apoptosis (8–11).
Clinical value of these fundamental findings is immense. They led to evolution of new 
translational therapeutic approaches in geriatric patients predisposed and exposed to SCC 
(12). The idea of overturning the fibroblast senescence phenotype by wounding modalities is 
now appealing clinically and will be further discussed in this review.
Risk factors for squamous cell carcinoma
NMSC, like other neoplastic pathologies, is characterized by multifactorial origin. Though 
the precise causal mechanism has not being defined, epidemiological studies suggest an 
interplay of genetic, environmental and advancing aging causalities. NMSC is more 
prevalent in males, patients who have light-colored skin and blue eyes, are 
immunosuppressed (primary or secondary), infected by human papilloma viruses (HPV) or 
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exhibit some chronic inflammatory states (scars, burns or sinus tracts). In addition, several 
genetically inherited cutaneous conditions could also carry high risk for NMSC, for instance 
xeroderma pigmentosum, oculocutaneous albinism and epidermodysplasia verruciformis 
(13,14).
However, the most likely direct causes of NMSC are sunlight and advancing age (5,15–17). 
This epidemiological link was well-established clinically, as more than 80% of NMSC 
patients are older than 60 and their lifestyle is connected to prolonged sunlight exposure 
(18). Nevertheless, this clinical observation has not offered a direct causal link between the 
three associated phenomena: the cancer, sun exposure and older age, instead–it geared basic 
science research toward linking UV radiation of sunlight and molecular mechanisms of 
carcinogenesis in elderly. Initial reports suggest that excessive sun exposure in juvenescence 
can cause accumulation of UBV-induced mutations in epidermal keratinocytes (19). These 
DNA alterations are not sufficient to cause the keratinocytes death but rather allow them to 
silently persist in epidermis for decades where they will progressively accumulate novel and 
certainly deleterious mutations. When the number of these DNA mutations in essential 
regulatory genes reaches still not defined threshold, abnormal keratinocyte divisions will 
ensue, initiating the tumor growth and making the cancer clinically apparent (20). However, 
this traditional approach of accumulation of chromosomal impairments has being non-
selectively applied to many neoplastic processes in oncology. In skin cancer pathogenesis, it 
relies on very weak mathematical premises that sun exposure in youth is higher than in 
adulthood and that skin defense strategy against malignancy remains unaltered throughout 
lifetime (18). Recently however, several groups have proved that neither was the case–as 
almost 80% of our exposure to sunlight occurs after puberty and this exposure remains 
constant throughout our lifetime (18,21). The UVB component in sunlight induces distinct 
types of DNA damage in keratinocytes, i.e. DNA single strand breaks, DNA interstrand 
cross-links, as well as nucleotide base modifications. Such DNA damages threaten genomic 
stability of keratinocytes forcing them to acquire adaptive behavior to effectively repair their 
DNA, successfully undergoing programmed cell death and/or purposely undergoing 
premature senescence so as to evade neoplastic transformation. Along these lines, several 
groups have shown the ability of aging skin to repair UV-induced oxidative DNA damage 
diminishes over time (22,23). This photoaging process is primarily due to loss of nuclear 
DNA base excision repair enzymes, as well as, DNA nucleotide excision repair enzymes 
(24).
Much research on the pathogenesis of photoaging has also implicated important roles for 
cytokines and growth factors (regeneration of epidermis), diminished melanogenesis 
(decreased melanin protection), and inefficient fibroblast deposition of collagenases and 
elastases (failure to remove misfolded collagen and elastin) (24). All of these basic science 
reports enlighten the complexity of NMSC pathogenesis further suggesting that NMSC is a 
gradually life-evolving sun induced process and as such partially manageable by actinic 
radiation protective therapy (25–27).
In the last decade, the IGF-1/IGF-1R signal transduction pathway has attracted much 
attention in the basic research community suggesting this pathway as a novel mechanism 
that might explain why NMSC is a disease of the elderly (7–11). Not only that this 
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mechanism highly correlates with clinical observations but it considerably enlightens the 
disease development in geriatric population. Additionally, its value stands in proposing 
possible preventive strategies that could target premalignant lesions like actinic keratosis 
(AK) and hopefully forestall their progress into clinically manifested disease in receptive 
patients.
Molecular basis of squamous cell carcinoma pathogenesis in elderly–a new concept
A key limitation of NMSC basic research was inability to sufficiently correlate obtained data 
with clinical and epidemiological studies - primarily how lifetime exposure to UV radiation 
leads to development of actinic malignancy in the senior population (5). To our knowledge, 
UVB-induced stromal changes in aging skin have scarcely been investigated as a 
contributing factor in pathogenesis of these neoplasms. Recently, new light has been shown 
on this phenomenon by proposing a paradigm that not only suggests direct causality between 
the two, but also offers the cancer preventive treatments based on skin rejuvenation 
procedures already available in many dermatological practices.
When UVB-photons hit the epidermis, they first damage keratinocyte nucleic acids causing 
their signature mutations. If these mutations are not repaired but rather preserved and carried 
on to subsequent keratinocytes’ offspring, these cells have a propensity to eventually 
undergo neoplastic transformation (28). This keratinocyte procarcinogenic fate is not as easy 
to achieve as they have developed constitutional mechanisms to fight UVB-induced DNA 
damage (29). Our basic research findings revealed that the IGF-1/IGF-1R signaling pathway 
in human skin is one of these protective mechanisms. This pathway is compartmentalized 
within the dermal-epidermal junction where dermal fibroblasts (for now unilaterally) 
regulate the keratinocyte differentiation destiny. The basic components of this signaling 
mechanism are a tyrosine kinase family member, the IGF-1R (30) expressed on 
keratinocytes and the IGF-1R binding ligand, IGF-1, secreted extracellularly by dermal 
fibroblasts.
While the IGF-1R is expressed on human epidermal keratinocytes, IGF-1 mRNA/protein is 
detected in dermal fibroblasts, and melanocytes, but not in keratinocytes (30). Hence, the 
predominant mechanism by which the keratinocyte’s IGF-1R can be activated is by IGF-1 
secreted by papillary dermal fibroblasts. This signaling synergistic mechanism is maintained 
throughout lifetime allowing normal survival and growth of healthy skin. The aging process 
significantly affects fibroblast’s ability to synthesize and secrete IGF-1 in vivo. 
Consequently, the paucity of IGF-1 ligand in aged dermis significantly diminishes IGF-1R 
activation on keratinocytes. This receptor activation is crucial for keratinocytes to effectively 
respond to UVB irradiation in aged skin. In young skin, IGF-1 synthesis and secretion are 
sufficient to maintain normal activity of the keratinocyte IGF-1R. When exposed to 
moderate levels of UVB, DNA of young keratinocytes undergoes radiation-induced damage. 
This damage, if it cannot be fully repaired, predestines keratinocytes to become senescent. 
Keratinocyte senescence is a tumor evasion mechanism which averts these cells from 
passing actinic-induced mutations to their daughter cells. Unfortunately, the geriatric 
keratinocytes due to inactivity of protective IGF-1R signaling are not able to induce 
senescent response under the same dose of UVB. This biological misfortune causes them to 
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propagate UVB-induced DNA damage and ultimately induce neoplastic transformation in 
keratinocytes (6,8).
The importance of the IGF-1/IGF-1R pathway comes into play when UVB irradiation is 
within intermediate intensity levels. If this pathway is active, this intermediated level of 
radiation causes intermediate levels of DNA damage. If this damage cannot be completely 
repaired, keratinocytes will undergo stress-induced senescence (6). This mechanism thus 
clears these cells from entering the cell cycle and propagating damage to subsequent 
generations. In addition, this mechanism still preserves these cells in epidermis therefore 
preventing the skin from losing its barrier function. By contrast, if IGF-1/IGF-1R pathway is 
inactive as is the case during sun exposure in the elderly, the keratinocytes with 
intermediately mutated DNA not only cannot repair their genome, but also will keep 
proliferating dispersing therefore further their neoplastic potential. However, high and low 
UVB doses appear not to depend on activity of the IGF-1/IGF-1R pathway. Keratinocytes 
with slightly damaged DNA are able to completely repair their genome and survive 
independently of the IGF-1R activity. Similarly, cells with substantially damaged DNA 
cannot be rescued by preserved IGF-1R activity and are entirely removed from skin by 
apoptosis (20).
Encouraged by this basic science work, we examined further applicability of the IGF-1R 
activation in clinics in order to understand increased susceptibility of geriatric patients to 
NMSC. We observed that skin of patients older than 65 contained more senescent dermal 
fibroblasts than skin of patients younger than 25. This increase correlated with decrease in 
IGF-1 expression and consequent epidermal IGF-1R activation. We found that IGF-1R 
activation is crucial for keratinocyte response to UVB irradiation as in its absence, UVB 
damaged basal keratinocytes are able to proliferate and propagate their sun-exposed DNA 
damage. Notably, by injecting recombinant IGF-1 into the dermis of geriatric patients we 
were able to restore healthy skin response to UVB irradiation demonstrating a reversible 
nature of this important signaling pathway, as well as opening new avenues for promising 
therapeutic interventions (6–8).
Prophylactic wounding therapies – a theory behind praxis
NMSC with its annual incidence of over 2 million cases still represents the most common 
cancer in the United States (1). Such a high incidence of these malignancies presents a 
significant clinical and economic burden to the United States healthcare system and urges a 
public demand for its control. Prevention of tumors before they become clinically 
manifested has always been the most affordable though not necessarily the most elusive way. 
SCC is considered to evolve from pre-cancerous entity - the actinic keratosis (AK) (31), a 
lesion previously been shown to be somewhat manageable by cryotherapy, curettage, 
electrosurgery and photodynamic therapy with 5-fluorouracil or topical imiquimod (32,33). 
It has been shown that if treat AK by these modalities early enough that the progression to 
SCC is highly unlikely. Still some patients do develop SCC recurrences within 2–5 year 
period advocating prolonged clinical surveillance of pre-cancerous lesions and consequently 
increasing financial cost to our healthcare system (20,34).
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Even though the efficiency of AK treatment modalities in clinics has been improved in 
recent years, the major progress has been primarily achieved by minimizing evolution of 
already existing AK or early grade SCC lesions. Additionally, these treatment modalities 
target only clinically confirmed lesions and miss histologically appearing silent skin which 
could harbor pre-malignant lesions. This unaffected skin in aged individuals will remain 
fertile ground for development of actinic pre- or neoplastic processes if left prophylactically 
untreated and further exposed to sun radiation. Therefore, in the light of recent basic science 
findings that aged skin is specifically susceptible to UVB, it is possible to further improve 
skin rejuvenation modalities by combining them with the dermal IGF-1 restoration 
strategies. With this goal in mind, these skin rejuvenation strategies will acquire a new role 
in modern dermatological practices that not only have cosmetic but also cancer prophylactic 
effects (34–38). Our group has already shown that dermabrasion and fractionated laser 
resurfacing are promising rejuvenation strategies that can fulfill these roles in modern 
dermatology (12). At this point it is still not known molecularly how these cosmetic 
modalities rejuvenate the skin and prevent its neoplastic transformation–they could just 
physically remove senescent fibroblast causing the “wounded” skin to repopulate itself with 
new cells or by activating migration cues of fibroblasts into the treated tissues or “simply” 
by affecting the cell signaling mechanisms that regulate gene expression, protein translation 
or stimulate protein secretion of IGF-1, collagen and elastin. Further translational research is 
therefore required to elucidate these beneficial molecular mechanisms before we can use 
their results successfully in clinical settings.
Remodeling therapies reverse aging-induced senescence
The recent advent of basic science data that highlight importance of dermal fibroblast 
senescence as a contributing, if not predominant, factor in geriatric skin propensity to 
develop UVB-induced neoplasms led us to test molecular signaling behind clinically 
successful skin resurfacing modalities that are shown to reinstate youthful signaling in 
geriatric patients (12,39). Our group has examined molecular mechanisms that underlie two 
clinically successful skin wounding modalities, a dermabrasion and fractionated laser 
resurfacing methods. Dermabrasion is a 40-year known wounding modality featured by 
superficial dermal lesioning by rough grain sandpaper. Initial research has documented that 
the production of new collagen fibrils underlies this wounding modality. We were curious to 
investigate molecular and cellular changes in volunteers undergoing this treatment. In order 
to analyze the skin of geriatric individuals (age > 65 years), we first dermabraded distinct 
areas of their skin; three months later, the dermabraded loci were exposed to medium doses 
of UVB and subsequently the punch-out biopsies were taken for histological and 
biochemical analyses. Our group was the first to show that dermabrasion produced skin 
scarce in senescent fibroblasts but with fully restored levels of dermal IGF-1 mRNA. In 
addition, histologically we observed accumulation of elliptical fibroblast-replicating nuclei, 
denser fibroblast distribution, restoration of collagen fiber layers in the dermis, recovery of 
undulating dermal-epidermal basal membrane, and increased number of replicative 
keratinocytes - all featured in younger skin. Importantly, the levels of restored IGF-1 were 
quite comparable to those detected in skin from young individuals (age < 30 years). 
Furthermore, we were not able to detect significant population of initiated (UVB-damaged) 
basal keratinocytes in dermabrasion-treated epidermis suggesting that the potential for 
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progression of these foci into SCC was drastically diminished (11). This work was 
pioneering since no-one before has shown reversible molecular signature induced by 
dermabrasion that could overcome favorably senile pro-carcinogenic UVB response. 
Interestingly, many epidemiological studies have documented that dermabrasion reduces the 
incidence of AK and SCC by 95% many years after the application. Still significant 
morbidity that remains after this procedure renders dermabrasion less favorable in a routine 
clinical praxis.
Although a powerful strategy, the significant cosmetically unacceptable outcomes associated 
with dermabrasion lead us to investigate whether another potent but less aggressive 
rejuvenation treatment, the fractionated laser resurfacing (FLR; using a 2790nm vittrium 
scandium gallium garnet ablative fractional resurfacing device; Pearl Fractional Laser, 
Cutera, Brisbane CA), is able to alleviate the inept UVB response of geriatric skin. In FLR a 
pulsating laser beam delivers high-energy to skin chromophores and tissue water. The 
energy of laser photon in interaction with skin surface diffracts and part of its energy 
releases as a heat. The energy of heat causes skin vaporization of tissue layers inducing 
formation of mini-wounds. These mini-wounds induce a discrete “wounding reactions” 
(discrete microscopic columns of ablated epidermis and dermis in regularly spaced arrays) 
and damage that is eventually repopulated by new skin cells (12). The clinical consequence 
of this treatment modality is increased superficial skin tension still more favorable than 
profound massive superficial lesions commonly observed after dermabrasion. Although the 
dermatological lasers have commonly being used in practice for almost two decades, their 
histological and molecular mechanism of actions on skin, especially in restoring inadequate 
UVB response in elderly, has not being fully elucidated. In order to thoroughly explore their 
mode of action, we examined the skin in elderly volunteers. We found that independently of 
tissue sun exposure, FLR reduced the proportion of senescent fibroblasts, increased the 
production of dermal IGF-1, and normalized the skin response to UVB in treated foci (Fig. 
1, 12). Notably, these effects were also observed in more aggressive dermabrasion 
procedure. More importantly, our basic science work offers an extension of clinical 
indications of FLR now to prophylaxis of future SCC. Extraordinarily, it appears that FLR 
provides extended protection of actinic-induced neoplasms for up to two years longer than 
commonly used sun protection methods in elderly. Although promising as a preventive 
strategy for skin cancer, ablative lasers in cosmetology are associated with various side 
effects mild (and common) like redness, itching, acne and skin discoloration but also with 
serious (and rare) like skin infection, blistering and permanent scarring. Apparently, more 
translation research is necessary to make this rejuvenation modality as comfortable as 
successful it is.
CONCLUSIONS
The novel work of several translational groups including ours has elucidated some 
mechanisms of skin resurfacing methodologies and proposes an extension of laser 
indications in clinical dermatology. Our effort to understand the nature of lasers and the 
biology of senescent fibroblasts in aged skin is ongoing. This new concept of restoring youth 
of skin by lasers will hopefully allow dermatologist to precisely dose the frequency, 
amplitude and timing of clinical lasers in order to diminish their side effects and offer as best 
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service as possible to their ever increasing elderly population. Moreover, the old adage “fight 
fire with fire” finds its full application in modern dermatology where a light-induced disease 
appears to be best treated with a light-preventive strategy.
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Figure 1. Model demonstrating influence of Fractionated Laser Resurfacing on the response of 
geriatric skin to UVB irradiation
The top two panels compare features of young adult skin (left panel) and geriatric skin (right 
panel). Notice atrophy of epidermis and flattening of basement membrane in the geriatric 
skin. The increased proportion of senescent fibroblasts in the geriatric skin, and 
corresponding decrease in IGF-1 expression, leads to an enhanced susceptibility to 
development of UVB-induced NMSC. Following FLR treatment of geriatric skin (lower 
panel), the thickness of epidermis is increased and there is a restoration of undulating nature 
of the epidermal/dermal junction. In addition, the proportion of senescent fibroblasts is 
reduced, the level of IGF-1 expression increased, and there is a decreased susceptibility to 
UVB-induced NMSC.
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